DOCSLIB.ORG

Precursors and Chemicals Frequently Used in the Illicit Manufacture of Narcotic Drugs and Psychotropic Substances 2018

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Precursors and Chemicals Frequently Used in the Illicit Manufacture of Narcotic Drugs and Psychotropic Substances 2018 INTERNATIONAL NARCOTICS CONTROL BOARD Precursors and chemicals frequently used in the illicit manufacture of narcotic drugs and psychotropic substances 2018 EMBARGO Observe release date: Not to be published or broadcast before Tuesday, 5 March 2019, at 1100 hours (CET) UNITED NATIONS CAUTION Reports published by the International Narcotics Control Board in 2018 TheReport of the International Narcotics Control Board for 2018 (E/INCB/2018/1) is supplemented by the following reports: Progress in ensuring adequate access to internationally controlled substances for medical and scientific purposes(E/INCB/2018/1/Supp.1) Narcotic Drugs: Estimated World Requirements for 2019—Statistics for 2017 (E/INCB/2018/2) Psychotropic Substances: Statistics for 2017—Assessments of Annual Medical and Scientific Requirements for Substances in Schedules II, III and IV of the Convention on Psychotropic Substances of 1971 (E/INCB/2018/3) Precursors and Chemicals Frequently Used in the Illicit Manufacture of Narcotic Drugs and Psychotropic Substances: Report of the International Narcotics Control Board for 2018 on the Implementation of Article 12 of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988 (E/INCB/2018/4) The updated lists of substances under international control, comprising narcotic drugs, psychotropic substances and substances frequently used in the illicit manufacture of narcotic drugs and psychotropic substances, are contained in the latest editions of the annexes to the statistical forms (“Yellow List”, “Green List” and “Red List”), which are also issued by the Board. Contacting the International Narcotics Control Board The secretariat of the Board may be reached at the following address: Vienna International Centre Room E-1339 P.O. Box 500 1400 Vienna Austria In addition, the following may be used to contact the secretariat: Telephone: (+43-1) 26060 Fax: (+43-1) 26060-5867 or 26060-5868 Email: [email protected] The text of the present report is also available on the website of the Board (www.incb.org). INTERNATIONAL NARCOTICS CONTROL BOARD Precursors and chemicals frequently used in the illicit manufacture of narcotic drugs and psychotropic substances Report of the International Narcotics Control Board for 2018 on the Implementation of article 12 of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988 UNITED NATIONS Vienna, 2019 E/INCB/2018/4 UNITED NATIONS PUBLICATION Sales No. E.19.XI.6 ISBN: 978-92-1-148312-3 eISBN: 978-92-1-047721-5 ISSN 2411-8664 eISSN 2411-8672 © United Nations: International Narcotics Control Board, January 2019. All rights reserved worldwide. Publishing production: English, Publishing and Library Section, United Nations Office at Vienna. Foreword I am pleased to present the analysis of the International Narcotics Control Board (INCB) regarding the world precursor situation in 2018. This year’s report marks the thirtieth anniversary of the conclu- sion of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988. Over the years, INCB has noted overall improvements in the prevention of the diversion of chemicals listed in Table I and Table II of the 1988 Convention through the monitoring of their international trade, as set out in article 12 of that Convention. However, some challenges are not adequately addressed by the existing international precursor control framework. Above all, I am referring to the emergence of non-scheduled chemicals including, most recently, “designer” precursors purposely made to circumvent controls. Other developments are not specific to precursor control but affect it in significant ways and present new challenges to global cooperation and coordination. Those include changes in global trade relations, communication and transportation. In that connection, the Board would like to recall its 2014 report on precursors and the thematic chapter entitled “Making precursor control fit for 2019 and beyond”. The theme of this year’s report is the proliferation of non-scheduled “designer” precursors and the Board’s reflection on possible ways to address it at the international level. It is the common thread run- ning through the present report, as illustrated by the fact that nearly half of the chapter about global trends in precursor trafficking is devoted to non-scheduled chemicals, including “designer” precursors. While it is important to find solutions that enable Governments worldwide to address the growing complexity and diversification of the problem, proven concepts in international precursor control also need to continue to be implemented to maintain the low level of diversion from international legiti- mate trade. This includes the applicable provisions of the 1988 Convention, precursor-related resolu- tions and established working mechanisms, such as the Pre-Export Notification Online system and the Precursors Incident Communication System. For some time now, INCB has been advocating a two-pronged approach with a focus on preventive action (such as voluntary cooperation with indus- try) and law enforcement action (investigating seizures and stopped shipments of chemicals that are known or suspected to be used for illicit purposes). Such a two-pronged approach can be taken to addressing both internationally controlled precursors and non-scheduled chemicals. INCB invites Governments to continue to work with each other and the Board within the established framework, and to develop new concepts together to make precursor control fit for the future and reduce the flow of chemicals that reach clandestine laboratories. Viroj Sumyai President of the International Narcotics Control Board iii Preface The United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988 requires the International Narcotics Control Board to report annually to the Commission on Narcotic Drugs on the implementation of article 12 of the Convention and requires the Commission to periodically review the adequacy and propriety of Table I and Table II of the Convention. In addition to its annual report and other technical publications on narcotic drugs and psychotropic substances, the Board has prepared its report on the implementation of article 12 of the 1988 Convention in accordance with the following provisions, contained in article 23 of the Convention: 1. The Board shall prepare an annual report on its work containing an analysis of the information at its disposal and, in appropriate cases, an account of the explanations, if any, given by or required of parties, together with any observations and recommendations which the Board desires to make. The Board may make such additional reports as it considers necessary. The reports shall be submitted to the Economic and Social Council through the Commission which may make such comments as it sees fit. 2. The reports of the Board shall be communicated to the parties and subsequently published by the Secretary-General. The parties shall permit their unrestricted distribution. v Contents Page Foreword . iii Preface . v Explanatory notes .................................................................................... xi Summary . xiii Chapter I. Introduction ............................................................................... 1 II. Action taken by Governments and the International Narcotics Control Board .................... 1 A. Scope of control ....................................................................... 1 B. Adherence to the 1988 Convention ...................................................... 2 C. Reporting to the Board pursuant to article 12 of the 1988 Convention ....................... 2 D. Legislation and control measures ........................................................ 3 E. Submission of data on licit trade in, uses of and requirements for precursors. 5 F. Annual legitimate requirements for imports of precursors of amphetamine-type stimulants .... 5 G. Pre-export notifications and utilization of the Pre-Export Notification Online system .......... 7 H. Other activities and achievements in international precursor control ......................... 10 III. Extent of licit trade and latest trends in trafficking in precursors ................................ 13 A. Substances used in the illicit manufacture of amphetamine-type stimulants. 13 B. Substances used in the illicit manufacture of cocaine ...................................... 26 C. Substances used in the illicit manufacture of heroin ....................................... 29 D. Substances used in the illicit manufacture of other narcotic drugs and psychotropic substances ............................................................................. 35 E. Substances not in Table I or Table II of the 1988 Convention that are used in the illicit manufacture of other narcotic drugs and psychotropic substances or substances of abuse not under international control .......................................................... 36 IV. Options to address the proliferation of non-scheduled “designer” precursors at the international level .......................................................................... 37 Glossary . 42 Annexes* I. Parties and non-parties to the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988, by region, as at 1 November 2018 ........ 43 II. Submission of information by Governments pursuant to article
Load more

Recommended publications
  • Scientific Assessment of Ephedra Species (Ephedra Spp.)
    Annex 3 Ref. Ares(2010)892815 – 02/12/2010 Recognising risks – Protecting Health Federal Institute for Risk Assessment Annex 2 to 5-3539-02-5591315 Scientific assessment of Ephedra species (Ephedra spp.) Purpose of assessment The Federal Office of Consumer Protection and Food Safety (BVL), in collaboration with the ALS working party on dietary foods, nutrition and classification issues, has compiled a hit list of 10 substances, the consumption of which may pose a health risk. These plants, which include Ephedra species (Ephedra L.) and preparations made from them, contain substances with a strong pharmacological and/or psychoactive effect. The Federal Ministry of Food, Agriculture and Consumer Protection has already asked the EU Commission to start the procedure under Article 8 of Regulation (EC) No 1925/2006 for these plants and preparations, for the purpose of including them in one of the three lists in Annex III. The assessment applies to ephedra alkaloid-containing ephedra haulm. The risk assessment of the plants was carried out on the basis of the Guidance on Safety Assessment of botanicals and botanical preparations intended for use as ingredients in food supplements published by the EFSA1 and the BfR guidelines on health assessments2. Result We know that ingestion of ephedra alkaloid-containing Ephedra haulm represents a risk from medicinal use in the USA and from the fact that it has now been banned as a food supplement in the USA. Serious unwanted and sometimes life-threatening side effects are associated with the ingestion of food supplements containing ephedra alkaloids. Due to the risks described, we would recommend that ephedra alkaloid-containing Ephedra haulm be classified in List A of Annex III to Regulation (EC) No 1925/2006.
    [Show full text]
  • Precursors and Chemicals Frequently Used in the Illicit Manufacture of Narcotic Drugs and Psychotropic Substances 2017
    INTERNATIONAL NARCOTICS CONTROL BOARD Precursors and chemicals frequently used in the illicit manufacture of narcotic drugs and psychotropic substances 2017 EMBARGO Observe release date: Not to be published or broadcast before Thursday, 1 March 2018, at 1100 hours (CET) UNITED NATIONS CAUTION Reports published by the International Narcotics Control Board in 2017 The Report of the International Narcotics Control Board for 2017 (E/INCB/2017/1) is supplemented by the following reports: Narcotic Drugs: Estimated World Requirements for 2018—Statistics for 2016 (E/INCB/2017/2) Psychotropic Substances: Statistics for 2016—Assessments of Annual Medical and Scientific Requirements for Substances in Schedules II, III and IV of the Convention on Psychotropic Substances of 1971 (E/INCB/2017/3) Precursors and Chemicals Frequently Used in the Illicit Manufacture of Narcotic Drugs and Psychotropic Substances: Report of the International Narcotics Control Board for 2017 on the Implementation of Article 12 of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988 (E/INCB/2017/4) The updated lists of substances under international control, comprising narcotic drugs, psychotropic substances and substances frequently used in the illicit manufacture of narcotic drugs and psychotropic substances, are contained in the latest editions of the annexes to the statistical forms (“Yellow List”, “Green List” and “Red List”), which are also issued by the Board. Contacting the International Narcotics Control Board The secretariat of the Board may be reached at the following address: Vienna International Centre Room E-1339 P.O. Box 500 1400 Vienna Austria In addition, the following may be used to contact the secretariat: Telephone: (+43-1) 26060 Fax: (+43-1) 26060-5867 or 26060-5868 Email: [email protected] The text of the present report is also available on the website of the Board (www.incb.org).
    [Show full text]
  • Incorporating Parents in the Anti-Doping Fight: a Test of the Viability of a Parent-Based Prevention Program
    1 Social Science Research Fund: Incorporating Parents in the Anti-Doping Fight: A Test of the Viability of a Parent-Based Prevention Program Final Report Submitted to: World Anti-Doping Agency Prepared by: Tonya Dodge, Ph.D. Skidmore College* *Investigator will be moving to The George Washington University Contact Information: Tonya Dodge, Ph.D. The George Washington University Department of psychology 2125 G Street, NW Washington, DC 20052 e-mail: [email protected] 2 Table of Contents Executive Summary.............................................................................................................................................. 3 Background ............................................................................................................................................................. 5 Interventions Targeting AS Use ....................................................................................................................... 6 Building Parent-Based Interventions: Considerations ........................................................................... 7 A Parent-Based Framework to Prevent AS and NS Use ......................................................................... 9 Study Aims ............................................................................................................................................................ 10 Methods ................................................................................................................................................................
    [Show full text]
  • Synthetic Drugs: Overview and Issues for Congress
    Synthetic Drugs: Overview and Issues for Congress Lisa N. Sacco Analyst in Illicit Drugs and Crime Policy Kristin Finklea Specialist in Domestic Security May 3, 2016 Congressional Research Service 7-5700 www.crs.gov R42066 Synthetic Drugs: Overview and Issues for Congress Summary Synthetic drugs, as opposed to natural drugs, are chemically produced in a laboratory. Their chemical structure can be either identical to or different from naturally occurring drugs, and their effects are designed to mimic or even enhance those of natural drugs. When produced clandestinely, they are not typically controlled pharmaceutical substances intended for legitimate medical use. Designer drugs are a form of synthetic drugs. They contain slightly modified molecular structures of illegal or controlled substances, and they are modified in order to circumvent existing drug laws. While the issue of synthetic drugs and their abuse is not new, Congress has demonstrated a renewed concern with the issue. From 2009 to 2011, synthetic drug abuse was reported to have dramatically increased. During this time period, calls to poison control centers for incidents relating to harmful effects of synthetic cannabinoids (such as “K2” and “Spice”) and stimulants (such as “bath salts”) increased at what some considered to be an alarming rate. The number of hospital emergency department visits involving synthetic cannabinoids more than doubled from 2010 to 2011. In 2012 and 2013, however, the number of calls to poison control centers for incidents relating to harmful effects of synthetic cannabinoids and synthetic stimulants decreased. Calls regarding bath salts have declined each year since 2011, while calls regarding synthetic cannabinoids have increased since the drops in 2012 and 2013.
    [Show full text]
  • 2020 International Narcotics Control Strategy Report
    United States Department of State Bureau for International Narcotics and Law Enforcement Affairs International Narcotics Control Strategy Report Volume I Drug and Chemical Control March 2020 INCSR 2020 Volume 1 Table of Contents Table of Contents Common Abbreviations ..................................................................................................................................... iii International Agreements.................................................................................................................................... v INTRODUCTION ..................................................................................................................................... 1 Legislative Basis for the INCSR ......................................................................................................................... 2 Presidential Determination ................................................................................................................................. 7 Policy and Program Developments .................................................................................................... 12 Overview ......................................................................................................................................................... 13 Methodology for U.S. Government Estimates of Illegal Drug Production .......................................................... 18 Parties to UN Conventions ..............................................................................................................................
    [Show full text]
  • Fall TNP Herbals.Pptx
    8/18/14 Introduc?on to Objecves Herbal Medicine ● Discuss history and role of psychedelic herbs Part II: Psychedelics, in medicine and illness. Legal Highs, and ● List herbs used as emerging legal and illicit Herbal Poisons drugs of abuse. ● Associate main plant and fungal families with Jason Schoneman RN, MS, AGCNS-BC representave poisonous compounds. The University of Texas at Aus?n ● Discuss clinical management of main toxic Schultes et al., 1992 compounds. Psychedelics Sacraments: spiritual tools or sacred medicine by non-Western cultures vs. Dangerous drugs of abuse vs. Research and clinical tools for mental and physical http://waynesword.palomar.edu/ww0703.htm disorders History History ● Shamanic divinaon ○ S;mulus for spirituality/religion http://orderofthesacredspiral.blogspot.com/2012/06/t- mckenna-on-psilocybin.html http://www.cosmicelk.net/Chukchidirections.htm 1 8/18/14 History History http://www.10zenmonkeys.com/2007/01/10/hallucinogenic- weapons-the-other-chemical-warfare/ http://rebloggy.com/post/love-music-hippie-psychedelic- woodstock http://fineartamerica.com/featured/misterio-profundo-pablo- amaringo.html History ● Psychotherapy ○ 20th century: un;l 1971 ● Recreaonal ○ S;mulus of U.S. cultural revolu;on http://qsciences.digi-info-broker.com http://www.uspharmacist.com/content/d/feature/c/38031/ http://en.wikipedia.org/nervous_system 2 8/18/14 Main Groups Main Groups Tryptamines LSD, Psilocybin, DMT, Ibogaine Other Ayahuasca, Fly agaric Phenethylamines MDMA, Mescaline, Myristicin Pseudo-hallucinogen Cannabis Dissociative
    [Show full text]
  • The Market for Amphetamine-Type Stimulants and Their Precursors in Oceania
    The market for amphetamine-type stimulants and their precursors in Oceania Andreas Schloenhardt Research and Public Policy Series No. 81 The market for amphetamine-type stimulants and their precursors in Oceania Andreas Schloenhardt Research and Public Policy Series No. 81 © Australian Institute of Criminology 2007 ISSN 1326-6004 ISBN 978 1 921185 53 3 Apart from any fair dealing for the purpose of private study, research, criticism or review, as permitted under the Copyright Act 1968 (Cth), no part of this publication may in any form or by any means (electronic, mechanical, microcopying, photocopying, recording or otherwise) be reproduced, stored in a retrieval system or transmitted without prior written permission. Inquiries should be addressed to the publisher. Project no. 0135 Published by the Australian Institute of Criminology GPO Box 2944 Canberra ACT 2601 Tel: (02) 6260 9272 Fax: (02) 6260 9299 Email: [email protected] Website: http://www.aic.gov.au Please note: minor revisions are occasionally made to publications after release. The online versions available on the AIC website will always include any revisions. Edited and typeset by the Australian Institute of Criminology A full list of publications in the Research and Public Policy Series can be found on the Australian Institute of Criminology website at http://www.aic.gov.au Director’s introduction In 2005, the United Nations Office on Drugs and Crime (2005) valued the global market for ATS at US$44 billion, approximately 13.8 percent of the global illicit drug market (at retail level). It has been estimated that Oceania accounts for about 9–10 percent of the global ATS market; a market share that is disproportionately large in relation to the small population of the region.
    [Show full text]
  • Dietary Supplements Containing Ephedrine Alkaloids
    SUMMARY OF DATA FOR CHEMICAL SELECTION Dietary Supplements Containing Ephedrine Alkaloids BASIS OF NOMINATION Dietary supplements containing ephedrine alkaloids from herbal sources (ephedra) are brought to the attention of the CSWG as part of an ongoing National Institutes of Health (NIH) Office of Dietary Supplements (ODS) research initiative on the safety and efficacy of these products. This initiative was recommended by the Senate Committee on Appropriations in fiscal year (FY) 2001. In its Report making FY 2002 appropriations for the Department of Health and Human Services, the Committee expressed pleasure that the ODS followed through on its FY 2001 recommendation and urged the ODS to continue and expand this important effort. The nomination of ephedra­ containing supplements to the National Toxicology Program (NTP) is part of the expanded effort by the ODS. As the Senate Committee noted, the number of Americans taking dietary supplements containing ephedra has risen dramatically. Dietary supplements containing herbal ephedra (chiefly Ephedra sinica Stapf.) are widely used as diet aids and athletic performance enhancers, with over 3 billion servings1 sold each year for weight loss alone. The active ingredients in these supplements are primarily ephedrine and pseudoephedrine with small amounts of other ephedrine alkaloids usually present. Ephedra-based diet aids often contain other stimulants, such as caffeine (guarana), as well as salicin, diuretics, and cathartics. Ephedra-containing performance enhancers often contain caffeine and other ingredients, such as chromium picolinate or l-carnitine, and may be consumed with other performance enhancers, such as androstenedione and creatine monohydrate. The ephedrine alkaloids are sympathomimetic amines, a class of compounds with fairly well characterized short to medium term biological activities.
    [Show full text]
  • Ephedra and Energy Drinks on College Campuses by Daniel Ari Kapner
    INFOFACTSRESOURCES The Higher Education Center for Alcohol and Other Drug Abuse and Violence Prevention Ephedra and Energy Drinks on College Campuses by Daniel Ari Kapner The February 2003 death of Baltimore Orioles pitcher levels . alertness and perception.”6,7 Also known found. Half of the events in which ephedra was the Steve Bechler, who according to the coroner’s report as ma huang, ephedra is considered a “natural” main contributing factor affected apparently healthy died after taking ephedrine alkaloids (ephedra), has supplement7 and Chinese herbalists have used the people under age 30.13 garnered national attention for the topic of nutri- herb Ephedra for thousands of years to treat asthma The Annals of Internal Medicine published a study tional supplements and energy drinks.1 While the and colds.8 Ephedra has been used in some over-the- in 2003 suggesting that ephedra accounted for 64 headlines have focused mainly on use by professional counter cold and asthma products in the United States.9 percent of all adverse reactions from herbal products athletes, these substances have gained popularity Until recently, ephedra was found in many weight- in 2001, even though it represented only 4.3 percent of among college-age students and are associated with loss and energy-enhancing products. Popular supple- industry sales in that year.14,15 the deaths of Florida State University linebacker ments that contained ephedra included Metabolife A study published in the New England Journal Devaughn Darling, Northwestern University football and Ripped Fuel, both of which are now available in of Medicine in 2000 examined 140 cases of ephedra- player Rashid Wheeler, and the University at Albany, ephedra-free formulations.
    [Show full text]
  • Chapter 1.Litho
    exploited by drug trafficking organizations. What is more, the rise in drug abuse in such countries has proven extremely difficult to contain because of INTRODUCTION fragmented and unprepared medical and health authorities. In situations of armed conflict, illicit Governments and international organizations drug revenues – or the drugs themselves – are regularly collect and analyze data on illicit drug regularly exchanged for arms. production, trafficking and consumption. In most cases, however, trends can be identified only indi- In a world that becomes increasingly complex, the rectly due to the inherently clandestine nature of scope for profit-making in the illicit drug trade is the activities. With this constraint acknowledged at rapidly expanding. The relationship between illicit the outset, this chapter seeks to describe global drugs and economic development, for example, is trends on the basis of available information. The far more important than generally recognized: overview may help to place in context trends and while it is widely accepted that illicit cultivation issues described in subsequent parts of this report. occurs in many developing countries, the effects of the illegal trade on local communities is all too The illicit drug phenomenon cannot be viewed often assumed to be cost-free. In fact, the spillover outside the context of contemporary economic, of production into abuse has a negative impact on social and political developments. Changes in the the local workforce. Illicit sector income is unevenly world political economy and advances in distributed; at the lower level of the production technology over the past three decades have had a chain it barely exceeds income in the licit sector.
    [Show full text]
  • A Systematic Review of Methamphetamine Precursor
    REVIEW doi:10.1111/j.1360-0443.2011.03582.x A systematic review of methamphetamine precursor regulationsadd_3582 1..14 Rebecca McKetin1,2, Rachel Sutherland2, David A. Bright2 & Melissa M. Norberg2 Centre for Mental Health Research,The Australian National University, Canberra, Australia1 and National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia2 ABSTRACT Aims To assess the effectiveness of methamphetamine precursor regulations in reducing illicit methamphetamine supply and use. Methods A systematic review of 12 databases was used to identify studies that had evaluated the impact of methamphetamine precursor regulations on methamphetamine supply and/or use. The guidelines of the Effective Practice and Organization of Care Group (EPOC) of The Cochrane Collaboration were used to determine which study designs were included and assess their quality. Results Ten studies met the inclusion criteria. These studies evaluated 15 interventions (13 regulations and two related interdiction efforts), all of which were located in North America. Interventions had consistent impacts across various indicators of methamphetamine supply and use. Seven of the 15 interventions produced reductions in methamphetamine indicators (ranging from 12% to 77%). Two of the largest impacts were seen following interdiction efforts, involving the closure of rogue pharmaceutical companies. There was no evidence of a shift into other types of drug use, or injecting use, although the impact on the synthetic drug market was not examined. Null effects were related largely to the existence of alternative sources of precursor chemicals or the availability of imported methamphetamine. Conclusions Methamphetamine precursor regulations can reduce indicators of methamphetamine supply and use. Further research is needed to determine whether regu- lations can be effective outside North America, particularly in developing countries, and what impact they have on the broader synthetic drug market.
    [Show full text]
  • Written Witness Statement for U.S. Sentencing Commission's Public
    STATEMENT OF TERRENCE L. BOOS, PH.D. SECTION CHIEF DRUG AND CHEMICAL EVALUATION SECTION DIVERSION CONTROL DIVISION DRUG ENFORCEMENT ADMINISTRATION and CASSANDRA PRIOLEAU, PH.D. DRUG SCIENCE SPECIALIST DRUG AND CHEMICAL EVALUATION SECTION DIVERSION CONTROL DIVISION DRUG ENFORCEMENT ADMINISTRATION - - - BEFORE THE UNITED STATES SENTENCING COMMISSION - - - HEARING ON SENTENCING POLICY FOR SYNTHETIC DRUGS - - - OCTOBER 4, 2017 WASHINGTON, D.C. 1 Introduction New Psychoactive Substances (NPS) are substances trafficked as alternatives to well- studied controlled substances of abuse. NPS have demonstrated adverse health effects such as paranoia, psychosis, and seizures to name a few. Cathinones, cannabinoids, and fentanyl-related substances are the most common NPS drug classes encountered on the illicit drug market, all with negative consequences for the user to include serious injury and death. Our early experience saw substances being introduced from past research efforts in an attempt to evade controls. This has evolved to NPS manufacturers structurally altering substances at a rapid pace with unknown outcomes to targeting specific user populations. These substances represent an unprecedented level of diversity and consequences. Due to clandestine manufacture and unscrupulous trafficking, the user is at great risk. A misconception exists that these substances carry a lower risk of harm In reality, published reports from law enforcement, emergency room physicians and scientists, accompanied with autopsies from medical examiners, have clearly demonstrated the harmful and potentially deadly consequences of using synthetic cathinones. These substances are introduced in an attempt to circumvent drug controls and the recent flood of NPS remains a challenge for law enforcement and public health. The United Nations Office on Drugs and Crime reported over 700 NPS encountered.1 The manufacturers and traffickers make minor changes in the chemical structure of known substances of abuse and maintain the pharmacological effect.
    [Show full text]